Overview
Alzheimer's Research UK is the premier dementia and Alzheimer's disease research charity in the United Kingdom. Established in 1992, the organization is committed to defeating dementia through groundbreaking research. Renowned for providing dependable, evidence-based information on dementia, Alzheimer's Research UK is distinct from Alzheimer’s Society, with unique goals and missions.
Vision and Mission
The charity envisions a world free from the debilitating impact of dementia, with a mission to find a cure. Its efforts include transformative initiatives focused on the treatment, diagnosis, and prevention of dementia, supported by substantial investment and strategic planning.
Organizational Structure
- Hilary Evans-Newton, Chief Executive, joined the organization in 2013, bringing extensive experience from Age UK and Age Concern. She is a co-chair of the Dame Barbara Windsor Dementia Goals Programme within the UK Government.
- Emma Whitcombe serves as Deputy Chief Executive and Executive Director of Fundraising and Marketing, spearheading efforts to gather support for research critical to those potentially affected by dementia.
- Samantha Benham-Hermetz leads the Policy, Communications, and Involvement directorate, focusing on access to medicines and influencing health policies.
- Debbie Clark heads Individual Giving and Legacy, optimizing various fundraising channels.
- Carolyne Coupel directs Strategic Marketing, aligning digital, brand, and insight strategies.
- Philip Dunn, as Executive Director of Finance & Operations since 2017, ensures the charity’s financial stability.
Financial Performance
Recent financial achievements of Alzheimer’s Research UK include:
- Raising £100 million via strategic partnerships and innovative fundraising.
- Investing £27 million in research recently, a significant step toward curing dementia.
- Generating an economic return of £2.59 for every £1 spent on dementia research in the UK.
Key Projects and Initiatives
Alzheimer's Research UK's strategic "Towards A Cure" roadmap defines its objectives through 2033, focusing on:
- Policymaking and government advocacy to benefit dementia-affected individuals.
- Funding innovative research to enhance medical treatments and diagnostics.
- Building strategic partnerships to boost scientific knowledge and community engagement.
Contact Information
The charity's office is located at 3 Riverside, Granta Park, Cambridge CB21 6AD. For further details or assistance, contact their Supporter Care Team at 0300 111 5555.
Strategic Goals
Alzheimer’s Research UK strives to advance dementia research through:
- Cutting-edge research investment.
- Establishing policy frameworks for timely therapy access.
- Conducting fundraising campaigns to increase research funds and public awareness.
Key Competitors
- AARP: Prominent in dementia research, especially through the "Disrupt Dementia" campaign and the Dementia Discovery Fund, focusing on dementia risk factors and public education.
- Alzheimer's Association: Since 1980, a leader in Alzheimer’s care, support, and research, accelerating global research initiatives and offering support services.
- Alzheimer's Research & Prevention Foundation (ARPF): Advocates prevention through their 4 Pillar Program and funds prevention research alongside brain longevity education.
- Dementia Society of America: Offers education, resources, and support, with a focus on advocacy and information on various dementia-related conditions.
Strategic Partnerships
As a founding member of the Dementia Consortium, Alzheimer’s Research UK actively engages with pharmaceutical companies like Evotec in a £9.5 million global effort to advance research and development in dementia treatment and prevention.
Accolades and Recognition
Recognized as one of the best workplaces in the East of England, the organization is commended for its outstanding team management and leadership, which enhances its appeal to potential collaborators and donors.
Research and Initiatives
Through collaborations with international research entities and pharmaceutical partners, Alzheimer's Research UK is engaged in major projects that enhance the understanding and treatment of Alzheimer’s. They are committed to improving diagnosis, treatment, and prevention through active participation in international initiatives.
